Recalls & Warnings
ConsumerLab.com is keeping you informed with current product recalls and warnings.
Posted July 23, 2013
Weight Loss Supplements Containing Undeclared Drugs Recalled
Sibutramine, the active ingredient in the obesity drug Meridia, was removed from the U.S. market in October 2010 because it can substantially increase blood pressure and pulse rate in some individuals, and may present a significant risk for patients with a history of coronary artery disease, congestive heart failure, arrhythmias, or stroke. This drug may also interact, in life-threatening ways, with other medications a consumer may be taking.
Esbelin siloutte Herbal Blend with L-Carnitine is promoted for normalizing nervous appetite, preventing fat accumulation and fluid retention in tissues. It is packaged in a white plastic bottle containing 30 capsules and can be identified by UPC # 7502011000060.
Esbelin siloutte te is promoted as a fat burner. It is packaged in a packaged in a gold resealable foil pouch and can be identified by UPC # 7562684652553.
Both supplements were sold nationwide in retail store and through internet sales.
Consumers who have purchased these supplements should discontinue use immediately and contact their healthcare provider if they have experienced any adverse side effects. Consumers and healthcare providers are also encouraged to report any adverse reactions to the FDA’s MedWatch Adverse Event Reporting Program.
See Related Warnings:
For more information about this recall, use the link below.